Investigational Site Number 840007
Louisville, Kentucky 40213
0 studies enrolling now · 3 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Ovarian Cancer Recurrent, Type 2 Diabetes
Studies at this site
- ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
- Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM — Completed
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer — Completed